Shawn Yazdani, MD, FACC, FSCAI

Interventional Cardiologist in Vienna, VA
Opening at 8:00 AM on Monday
Header image for the site


Tricuspid regurgitation (TR) has generally been ignored in the therapeutic algorithm of patients with heart disease. There are several reasons for that. Perhaps the most common reason is that almost 90 percent of patients with severe tricuspid regurgitation have left sided heart disease such as m...

Read More
Learn more

The latest advances in cardiology technology and research were presented recently at the American College of Cardiology (ACC) Annual Conference held in New Orleans. Among which included the “hotly anticipated new randomized clinical trials testing transcatheter aortic valve replacement (TAVR) in ...

Read More
Learn more

Read Dr. Yazdani's recently updated blog, A Tale of Two Valves, which takes a closer look at Transcatheter Aortic Valve Replacement (TAVR) as a treatment for the heart condition known as aortic valve stenosis.

Learn more


5 months ago
Dr. Yazdani has helped me with a serious heart condition over the last 18 years. He is a great person, makes you feel at ease, and I highly recommend him to anyone looking for a great cardiologist.
- Said A
11 months ago
Dr. Yazdani saved my grandfather’s life. He was compassionate and involved in his care both in the hospital and out. He took the time to answer any and all questions he and the rest of the family had regarding his condition and continues to be active in his care. He provided the tools to properly educate my grandfather, who until his recent heart attack had never been on any medications. He made sure he felt comfortable and capable and continues to do so. There is no other physician I would rather have involved in his care. He is not just a great doctor but a great man.
- Eve R
6 months ago
Thankful mr; Shawn yazdani
- Sohrab B

About us

Dr. Shawn Yazdani is one of the area’s most renowned interventional cardiologists, known for his specialization in structural heart care and innovative approach to interventional cardiology. 

He was the first operator in Northern Virginia to switch to the radial access uniformly in his practice, a method now adopted by most operators in the area.

He then became a cofounder of Carient Heart and Vascular.

Starting the first Chronic Total Occlusion (CTO) program during his time at INOVA, he has today performed the greatest number of successful procedures in the area.   

Leading the way for new interventional techniques, Dr. Yazdani has performed more CTO procedures than any other interventional cardiologist in the area, applying new techniques to successfully open these types of arteries unresponsive to conventional interventional techniques and relieve once life-limiting symptoms for patients across Virginia.  

He has over two decades of experience treating complex coronary lesions utilizing atherectomy, thrombectomy, hemodynamic support and other results-driven, evidence based techniques with a focus on patient outcome. 

Dr. Yazdani became interested in treating structural heart disease in 2012 when science supported the use of transcatheter aortic valve replacement (TAVR) techniques, in lieu of open heart surgery, to treat aortic valve disease, specifically aortic stenosis. 

He was involved in the initial trials observing transcatheter therapy in patients at high or prohibitive risk for surgical valve replacement. Since then, he has served as primary investigator in many other trials, including Partner 3, Early TAVR, and Galileo. He has been the lead physician in bringing non-surgical alternative access, such as Transcaval valve replacement, to Northern Virginia - for patients who do not have good femoral access for valve delivery. 

Dr. Yazdani has performed more TAVR procedures in Northern Virginia than any other operator. 

He remains involved in research and continues to pioneer nonsurgical catheter based treatments.

Though only a few physicians were performing this procedure nationwide, he has since broadened it popularly and become instrumental in bringing to the area different mitral valve treatment modalities, such as Lampoon (laceration of the anterior leaflet of the mitral valve prior to transcatheter replacement of the mitral valve), to the area. 

He is the primary investigator for the Apollo trials, involving transcatheter replacement of the mitral valve, or transcatheter mitral valve replacement (TMVR), in patients at high or intermediate risk for surgical valve replacement. He is also known for his expertise in mitral valve repair therapies such as MitraClip.

Dr. Yazdani is also involved in therapies geared towards patients with atrial fibrillation (AFib) and at high risk for taking blood thinners such as Coumadin. 

He regularly performs implantation of Left Atrial Appendage (LAA) Occluders such as the WATCHMAN™ device. 

Despite having a busy interventional practice, he also holds regular office hours in multiple locations in Northern Virginia including Vienna, Manassas and Warrenton. 

Dr. Yazdani completed both his undergraduate degree in Biology and his medical degree at New York University. 

His postgraduate training included a residency in internal medicine, followed by a Cardiology residency at Columbia Presbyterian Hospital. He then finished his interventional training at Mount Sinai Hospital. 

Professional Affiliations 

Fellow, American College of Cardiology (FACC)
Fellow, Society of Coronary Angiography and Intervention (FSCAI)    

Carient Heart & Vascular Office Locations

Vienna Office
415 Church Street NE, 101
Vienna, VA 22180

Manassas Office
8100 Ashton Avenue, Suite 200
Manassas, VA  20109

Warrenton Office
559 Frost Avenue, Suite 102
Warrenton, VA  20186

Contact Us


Call now
  • (877) 415-4116


Get directions
415 Church St Northeast
Vienna, VA 22180
United States

Business Hours

Mon:8:00 AM – 5:00 PM
Tue:8:00 AM – 5:00 PM
Wed:8:00 AM – 5:00 PM
Thu:8:00 AM – 5:00 PM
Fri:8:00 AM – 5:00 PM
Get quote
Message sent. We'll get back to you soon.